8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Boston Scientific ($BSX) issued a press release on Feb 4, 2026 announcing financial results for the fourth…
Filed with the SEC on · Summarized by InvestorsBot
Boston Scientific ($BSX) issued a press release on Feb 4, 2026 announcing financial results for the fourth quarter and full year ended Dec 31, 2025. Release is furnished as Exhibit 99.1 — review for revenue, EPS and commentary. 📣📊 #BSX #Earnings #MedTech
Note: The Item 2.02 disclosure and Exhibit 99.1 are furnished (Feb 4, 2026) and are not “filed” under Section 18 of the Exchange Act and are not incorporated by reference in other filings — limits Section 18 liability. 📝⚖️ $BSX #Regulatory #SEC